Esmael, Asnaira C.

HRN: 25-47-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2024
CEFTRIAXONE 1G (VIAL)
07/13/2024
07/19/2024
IV
2 Grams
Once A Day
Urinary Tract Infection
Waiting Final Action 
07/13/2024
AZITHROMYCIN 500MG TABLET (TAB)
07/13/2024
07/17/2024
ORAL
500mg
Once A Day
CAP-MR
Waiting Final Action 
07/19/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/19/2024
07/25/2024
IV
500mg
Q8
Post Cs
Waiting Final Action 
07/19/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/19/2024
07/25/2024
IV
4.5 G
Q6
CAP HR
Waiting Final Action 
07/31/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/24/2024
08/01/2024
IV
4.5gm
Q6
Septicemia
Waiting Final Action 
08/02/2024
MEBENDAZOLE 500MG (TAB)
08/02/2024
08/02/2024
PO
500mgtab
Single Dose
Ascariasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: